Morning Market Movers

Cubist Pharmaceuticals

shares climbed 35.66% to $100.88 after Merck

announced its plans to acquire Cubist for $102 per share in cash. BioLineRx

shares jumped 17.47% to $1.74 after the company reported positive data from ongoing Phase 2a Study for AML treatment. Louisiana-Pacific

shares gained 9.85% to $17.03. Louisiana-Pacific shares have dropped 3.85% over the past 52 weeks, while the S&P 500 index has gained 14.76% in the same period. Acceleron Pharma

rose 7.56% to $40.40. Celgene

and Acceleron announced new data from Luspatercept Phase 2 clinical trial in beta-thalassemia. Agios Pharmaceuticals

shares surged 3.42% to $109.65 after the company reported Celgene decision to extend discovery phase of global strategic collaboration to April 2016. The company also announced positive data from ongoing Phase 1 trial of AG-221 at ASH Annual Meeting. Randgold Resources

shares jumped 2.76% to $66.64 after falling 2.26% on Friday. Celgene

shares climbed 2.42% to $116.89 after the company and Acceleron Pharma

announced new data from Luspatercept Phase 2 clinical trial in beta-thalassemia. The Nasdaq OMX Group

rose 1.53% to $46.38 after analysts at Keefe Bruyette & Woods upgraded the stock from Market Perform to Outperform and raised the price target from $45 to $55.